Efficacy and Safety of 6.25 mg t.i.d. Feverfew CO2-Extract (MIG-99) in Migraine Prevention — A Randomized, Double-Blind, Multicentre, Placebo-Controlled Study
Titel:
Efficacy and Safety of 6.25 mg t.i.d. Feverfew CO2-Extract (MIG-99) in Migraine Prevention — A Randomized, Double-Blind, Multicentre, Placebo-Controlled Study
Auteur:
Diener, HC Pfaffenrath, V Schnitker, J Friede, M Zepelin, H-H Henneicke-von